Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
LAStandard BioTools Inc. logo

Standard BioTools Inc. (LAB)

NASDAQ · Currency in USD
$0.61 ▼ -0.03 (-4.72%)
At close: Oct 23, 4:00 PM ET. Market closed.
$0.62 ▲ +0.01 (+1.92%)
After hours: Oct 23, 7:30 PM ET

Summary

Previous Close
$0.64
Open
$0.63
Day's Range
$0.59 – $0.63
52 Week Range
$0.59 – $1.72
Volume
852,999
Avg. Volume
2,836,940
Market Cap
$237.75M
Beta (5Y Monthly)
1.35
PE Ratio (TTM)
--
EPS (TTM)
-$0.22
Earnings Date
Nov 3, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$3.25

Profile: Standard BioTools Inc.

Sector
Healthcare
Industry
Medical - Specialties
Full-time employees
387
CEO
Michael Egholm

Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through Proteomics and Genomics segments. Its proteomics and genomics include instruments, consumables, and assays for clinical and diagnostic uses.

Earnings

Next report: Tue, Nov 3, 2026
EPS estimate -$0.02 · Revenue est. $18.80M
DateEst.Actual
Aug 5, 2026-$0.01-$0.07Miss
May 5, 2026-$0.02-$0.02Beat
Feb 24, 2026-$0.03$0.06Beat
Nov 4, 2025-$0.04-$0.09Miss
Aug 11, 2025-$0.04-$0.04Beat
May 6, 2025-$0.04-$0.04Beat

Analyst view

Consensus price target
$3.25 ▲ +436.7%
Range $3.25 – $3.25
Rating: Buy
Buy 60% · Hold 40% · Sell 0%

Get free alerts on LAB and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.